by using the FDA's MedWatch Safety Information and Adverse Event Reporting Program: Complete and submit the report online. Download the form or call 1-800-332-1088 to request a reporting form sent ...

The recall has been issued for some products due to higher than acceptable levels of benzene, a chemical linked to leukemia and other blood disorders.

An appointment with Wendell Helveston, M.D., a neurologist in Hattiesburg, MS, led to a series of diagnostic tests, such as ...

Gozellix®, after radiolabeling with 68 Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

Neurocrine Biosciences, Inc.  today presented new data from the long-term, open-label KINECT® 4 study demonstrating remission of tardive dyskinesia among the majority of patients treated with ...

Under the agreement, Rhythm has agreed to repay $6.3 million in cash to RareStone. Rhythm also agreed to return all shares of RareStone that were acquired under the original agreement for no ...

Side effects may vary depending on the form of semaglutide you use. For more information about the possible ... you’ve had with semaglutide, visit MedWatch or call 800-FDA-1088.

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...

This press release and further information about Tonix can be found at ... Investors should read the risk factors set forth in the Annual Report on Form 10-K for the year ended December 31, 2023, as ...

Investors should read the risk factors set forth in the Annual Report on Form 10-K for the year ended December 31 ... by all ...

ZUNVEYL (benzgalantamine) is a twice-daily treatment designed to address the cognitive symptoms of mild-to-moderate Alzheimer’s disease. By enhancing cholinergic function in the brain, ZUNVEYL ...